The company has R&D and management teams in Guangzhou, China and San Francisco, USA. There are 500 square meters of experimental and office space in Guangzhou, with 10,000-level cell rooms and SPF-level animal rooms, which can carry out in vivo and in vitro screening, drug-making research and exploratory toxicological research. The company also makes full use of domestic perfect and high-quality CRO service companies to further promote the pre-clinical research and development of new drugs, and complete the Sino-US IND double report of the project.